5.6268

1.55% -0.1032

Bausch Health Companies Inc (BHC)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt BHC? Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$5.73

Offen:

$5.75

24-Stunden-Volumen:

1.40M

Relative Volume:

0.56

Marktkapitalisierung:

$2.09B

Einnahmen:

$9.47B

Nettoeinkommen (Verlust:

$-178.00M

KGV:

-11.72

EPS:

-0.48

Netto-Cashflow:

$1.01B

1W Leistung:

-7.67%

1M Leistung:

-0.33%

6M Leistung:

-21.76%

1J Leistung:

-19.52%

1-Tages-Spanne:

$5.565

$5.77

1-Wochen-Bereich:

$5.565

$6.095

52-Wochen-Spanne:

$4.25

$8.685

Bausch Health Companies Inc Stock (BHC) Company Profile

Firmenname

Bausch Health Companies Inc

Sektor

Healthcare (1113)

Branche

Drug Manufacturers - Specialty & Generic (83)

Telefon

514-744-6792

Adresse

2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC

Mitarbeiter

20,300

Twitter

Nächster Verdiensttermin

2024-10-30

Neueste SEC-Einreichungen

BHC's Discussions on Twitter

Compare BHC vs TAK, ZTS, HLN, TEVA, UTHR

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
BHC Bausch Health Companies Inc	5.645	2.12B	9.47B	-178.00M	1.01B	-0.48
TAK Takeda Pharmaceutical Co Adr	18.21	57.12B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	126.81	53.16B	9.47B	2.67B	2.28B	6.0218
HLN Haleon Plc Adr	10.46	47.25B	14.54B	2.22B	2.58B	0.4879
TEVA Teva Pharmaceutical Industries Ltd Adr	32.44	37.59B	17.41B	1.43B	1.00B	1.2182
UTHR United Therapeutics Corp	487.53	21.85B	3.13B	1.27B	1.12B	26.39

Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-12-09	Eingeleitet	Barclays	Equal Weight
2024-08-02	Herabstufung	Piper Sandler	Neutral → Underweight
2024-07-10	Eingeleitet	Raymond James	Mkt Perform
2023-09-20	Hochstufung	Jefferies	Hold → Buy
2023-06-16	Herabstufung	TD Cowen	Outperform → Market Perform
2022-07-29	Herabstufung	RBC Capital Mkts	Outperform → Sector Perform
2022-07-29	Herabstufung	Truist	Buy → Hold
2022-07-28	Herabstufung	JP Morgan	Overweight → Neutral
2022-06-13	Fortgesetzt	JP Morgan	Overweight
2021-03-24	Herabstufung	BofA Securities	Neutral → Underperform
2021-02-17	Hochstufung	RBC Capital Mkts	Sector Perform → Outperform
2021-01-22	Herabstufung	Piper Sandler	Overweight → Neutral
2020-09-17	Hochstufung	BofA Securities	Underperform → Neutral
2020-08-24	Bestätigt	H.C. Wainwright	Buy
2020-06-17	Bestätigt	H.C. Wainwright	Buy
2020-04-24	Eingeleitet	Citigroup	Buy
2020-04-02	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2020-01-29	Herabstufung	Wolfe Research	Outperform → Peer Perform
2020-01-22	Hochstufung	Wells Fargo	Underweight → Equal Weight
2019-12-12	Hochstufung	JP Morgan	Neutral → Overweight
2019-12-02	Eingeleitet	Goldman	Neutral
2019-10-25	Eingeleitet	Cowen	Outperform
2019-09-12	Eingeleitet	Guggenheim	Buy
2019-08-15	Hochstufung	TD Securities	Hold → Buy
2019-07-19	Eingeleitet	Wolfe Research	Outperform
2019-06-11	Fortgesetzt	Barclays	Overweight
2019-05-13	Hochstufung	JP Morgan	Underweight → Neutral
2019-03-20	Eingeleitet	SunTrust	Buy
2019-01-02	Hochstufung	Piper Jaffray	Neutral → Overweight
2018-11-05	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2018-09-13	Hochstufung	Piper Jaffray	Underweight → Neutral

Alle ansehen

Bausch Health Companies Inc Aktie (BHC) Neueste Nachrichten

Mar 03, 2026

Bausch Health (NYSE: BHC) CFO reports tax-withholding share disposition - Stock Titan

Mar 03, 2026

Bausch Health (BHC) EVP Carson trades shares, settles equity awards - Stock Titan

Mar 03, 2026

Tax withholding and cash PSU settlement for Bausch Health (BHC) CEO - Stock Titan

Mar 03, 2026

Seana Carson reports sales of 8,388 and 6,856 shares — BHC (NYSE: BHC) - Stock Titan

Mar 03, 2026

Mar 02, 2026

Bausch Health updates executive compensation agreements to cash settlement for 2023 PSUs - Investing.com Canada

Mar 02, 2026

Bausch Health updates executive compensation agreements to cash settlement for 2023 PSUs By Investing.com - Investing.com Australia

Mar 02, 2026

Bausch Health (NYSE: BHC) converts 2023 executive PSUs into cash-settled awards - Stock Titan

Mar 02, 2026

Bausch Health (NYSE:BHC) Stability Story Amid Canada Pharma Shifts Nyse Composite Today - Kalkine Media

Mar 02, 2026

Proposed insider sale at BHC (NYSE: BHC) — 6,856 common shares - Stock Titan

Mar 02, 2026

Bausch Health Cos Inc. (NYSE:BHC) Receives Average Rating of "Reduce" from Analysts - MarketBeat

Mar 02, 2026

Bausch Health Marks Arestin Milestone And Highlights Niche Dental Opportunity - Sahm

Mar 02, 2026

Feb 28, 2026

Is Bausch Health (BHC) Pricing Reflect Its Sharp Multi‑Year Share Price Declines? - Sahm

Feb 28, 2026

Assessing Bausch Health (BHC) Valuation After Years Of Weak Returns And Ongoing Debt Reduction Efforts - Sahm

Feb 28, 2026

Feb 27, 2026

Bausch Health (BHC) SVP Steven Lee receives 45,868 restricted share units - Stock Titan

Feb 27, 2026

Bausch Health (NYSE: BHC) EVP receives RSU grant, tax shares withheld - Stock Titan

Feb 27, 2026

Insider moves at Bausch Health (BHC): RSU grant, tax shares, open-market sale - Stock Titan

Feb 27, 2026

Bausch Health (NYSE: BHC) CFO awarded RSUs; shares withheld for tax obligations - Stock Titan

Feb 27, 2026

Should Bausch Health’s Profit Return and 2026 Outlook Shift the Investment Case for BHC? - Yahoo Finance

Feb 27, 2026

Feb 25, 2026

BHC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Feb 25, 2026

Bausch Health Cos (NYSE:BHC) Price Target Cut to $7.00 by Analysts at Barclays - MarketBeat

Feb 25, 2026

Signal Recap: Is now the right time to enter SAIAQuarterly Market Summary & Daily Entry Point Trade Alerts - baoquankhu1.vn

Feb 25, 2026

EV Market: Is Bausch Health Companies Inc backed by strong institutional buyingMarket Volume Summary & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn

Feb 25, 2026

Bausch Health (NYSE: BHC) CEO granted 815K RSUs, 116K shares withheld for tax - Stock Titan

Feb 25, 2026

Feb 24, 2026